Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Accenture
Cantor Fitzgerald
Fish and Richardson
Colorcon
Chubb
Cerilliant
Moodys
McKinsey
Dow

Generated: January 22, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,744,475

« Back to Dashboard

Summary for Patent: 5,744,475
Title: Uracil derivatives, and antitumor effect potentiator and antitumor agent containing the same
Abstract:The invention relates to novel uracil derivatives having excellent inhibiting effects of human derived thymidine phosphorylase and anti-tumor activity. The pharmaceutical compositions, anti-tumor potentiators, antitumor agents containing such novel compounds, and a process for their preparation and use is described. The novel compounds satisfy the general formula (1): ##STR1##
Inventor(s): Yano; Shingo (Kawagoe, JP), Tada; Yukio (Higashimatsuyama, JP), Kazuno; Hideki (Hanno, JP), Sato; Tsutomu (Hanno, JP), Yamashita; Junichi (Honjo, JP), Suzuki; Norihiko (Hidaka, JP), Emura; Tomohiro (Iruma, JP), Fukushima; Masakazu (Hanno, JP), Asao; Tetsuji (Tokorozawa, JP)
Assignee: Taiho Pharmaceutical Co., Ltd. (Tokyo, JP)
Application Number:08/737,677
Patent Claim Types:
see list of patent claims
Compound; Composition; Use;

Drugs Protected by US Patent 5,744,475

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,744,475

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan7-071667Mar 29, 1995
PCT Information
PCT FiledMarch 28, 1996PCT Application Number:PCT/JP96/00828
PCT Publication Date:October 03, 1996PCT Publication Number: WO96/30346

International Patents Family Members for US Patent 5,744,475

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 245631 ➤ Subscribe
Australia 5121696 ➤ Subscribe
Australia 681321 ➤ Subscribe
Canada 2191340 ➤ Subscribe
Germany 69629156 ➤ Subscribe
Denmark 0763529 ➤ Subscribe
European Patent Office 0763529 ➤ Subscribe
Spain 2203683 ➤ Subscribe
Hungary 227726 ➤ Subscribe
Hungary 9603280 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
Queensland Health
McKinsey
Johnson and Johnson
Boehringer Ingelheim
Harvard Business School
Merck
Novartis
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot